Wins an export order for “Cerviray” at the Mongolia international exhibition “Health Technology 2022”

Medical AI solution company AIDOT (CEO Jeong Jae-hoon) announced on the 16th that it signed an export contract worth USD 30,000 for its cervical cancer screening system “Cerviray” at the international exhibition “Health Technology 2022,” held in Ulaanbaatar, Mongolia.

A total of 80 organizations participated in the exhibition, including 13 public and private hospitals in Mongolia, 14 medical device and equipment organizations, and 41 pharmaceutical factories and medicine supply organizations.

Cerviray, an AI-based cervical cancer interpretation system, combines a portable device with software that displays the presence or absence of disease, severity, and disease status.

AIDOT is currently conducting a pilot project for 300 patients in Mongolia’s Gobi region, centered around Dr. Bayarsaikhan Luvsandorj, a former physician at the National Cancer Center, and plans to expand nationwide next year to begin full-scale cervical cancer screening.

An AIDOT representative said, “A contract has been finalized with a local Mongolian medical device company, and we have secured an initial export volume of more than USD 30,000,” adding, “Next year, we will spare no effort in eradicating cervical cancer in Mongolia by utilizing international support funds such as UN international funds.”

Published: October 16, 2022 / DailyMedi / Reporter Gu Gyo-yoon